Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06456736

Clinical Features and Prognostic Markers in Adult Patients With AE Requiring ICU Treatment

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Central South University · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

Autoimmune encephalitis (AE) is a potentially life-threatening inflammation of the central nervous system (CNS) and constitutes 20%-30% of encephalitis cases in adults AE often leads to subacute, severe, and debilitating encephalitis necessitating long-term management in a neurologic intensive care unit (ICU). This study aims to explore the predictive factors for poor clinical outcomes by analyzing the clinical characteristics and prognosis of adult patients with critical AE requiring ICU admission. Prospective observational single center study in neurologic ICU, the second Xiangya hospital, Central South University. All patients admitted to the ICU for probable or confirmed AE (2022 Chinese guidelines for diagnosis and treatment of AE) will be included. Factors associated with a poor prognosis will be identified by multivariate analysis using a logistic regression.

Conditions

Interventions

TypeNameDescription
OTHERNone, non-interventional studyNot applicable, non-interventional study

Timeline

Start date
2024-06-01
Primary completion
2024-07-01
Completion
2024-08-01
First posted
2024-06-13
Last updated
2024-06-13

Source: ClinicalTrials.gov record NCT06456736. Inclusion in this directory is not an endorsement.

Clinical Features and Prognostic Markers in Adult Patients With AE Requiring ICU Treatment (NCT06456736) · Clinical Trials Directory